Hongbin Ji
Hongbin Ji
Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese
Verified email at - Homepage
Cited by
Cited by
ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
K Bergethon, AT Shaw, SH Ignatius Ou, R Katayama, CM Lovly, ...
Journal of clinical oncology 30 (8), 863-870, 2012
LKB1 modulates lung cancer differentiation and metastasis
H Ji, MR Ramsey, DN Hayes, C Fan, K McNamara, P Kozlowski, C Torrice, ...
Nature 448 (7155), 807-810, 2007
Neutrophil elastase–mediated degradation of IRS-1 accelerates lung tumor growth
AMG Houghton, DM Rzymkiewicz, H Ji, AD Gregory, EE Egea, HE Metz, ...
Nature medicine 16 (2), 219-223, 2010
A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer
S Jiao, H Wang, Z Shi, A Dong, W Zhang, X Song, F He, Y Wang, Z Zhang, ...
Cancer cell 25 (2), 166-180, 2014
RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer
R Wang, H Hu, Y Pan, Y Li, T Ye, C Li, X Luo, L Wang, H Li, Y Zhang, F Li, ...
Journal of clinical oncology 30 (35), 4352-4359, 2012
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies
H Ji, D Li, L Chen, T Shimamura, S Kobayashi, K McNamara, U Mahmood, ...
Cancer cell 9 (6), 485-495, 2006
High-resolution genomic profiles of human lung cancer
G Tonon, KK Wong, G Maulik, C Brennan, B Feng, Y Zhang, DB Khatry, ...
Proceedings of the National Academy of Sciences 102 (27), 9625-9630, 2005
Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases
Y Sun, Y Ren, Z Fang, C Li, R Fang, B Gao, X Han, W Tian, W Pao, ...
Journal of clinical oncology 28 (30), 4616, 2010
Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression
C Xu, CM Fillmore, S Koyama, H Wu, Y Zhao, Z Chen, GS Herter-Sprie, ...
Cancer cell 25 (5), 590-604, 2014
Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors
H Ji, X Zhao, Y Yuza, T Shimamura, D Li, A Protopopov, BL Jung, ...
Proceedings of the National Academy of Sciences 103 (20), 7817-7822, 2006
VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex
W Zhang, Y Gao, P Li, Z Shi, T Guo, F Li, X Han, Y Feng, C Zheng, ...
Cell research 24 (3), 331-343, 2014
An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor
S Kobayashi, H Ji, Y Yuza, M Meyerson, KK Wong, DG Tenen, B Halmos
Cancer research 65 (16), 7096-7101, 2005
K-ras activation generates an inflammatory response in lung tumors
H Ji, AM Houghton, TJ Mariani, S Perera, CB Kim, R Padera, G Tonon, ...
Oncogene 25 (14), 2105-2112, 2006
MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene
R Fang, T Xiao, Z Fang, Y Sun, F Li, Y Gao, Y Feng, L Li, Y Wang, X Liu, ...
Journal of Biological Chemistry 287 (27), 23227-23235, 2012
YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
Y Shi, S Fan, M Wu, Z Zuo, X Li, L Jiang, Q Shen, P Xu, L Zeng, Y Zhou, ...
Nature communications 10 (1), 4892, 2019
Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression
H Ji, G Liao, WA Faubion, AC Abadía-Molina, C Cozzo, FS Laroux, ...
The Journal of Immunology 172 (10), 5823-5827, 2004
Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth
Y Yin, X Cai, X Chen, H Liang, Y Zhang, J Li, Z Wang, X Chen, W Zhang, ...
Cell research 24 (10), 1164-1180, 2014
Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers
C Li, R Fang, Y Sun, X Han, F Li, B Gao, AJ Iafrate, XY Liu, W Pao, ...
PloS one 6 (11), e28204, 2011
Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy
D Li, T Shimamura, H Ji, L Chen, HJ Haringsma, K McNamara, MC Liang, ...
Cancer cell 12 (1), 81-93, 2007
Heterogeneous mechanisms of primary and acquired resistance to third-generation EGFR inhibitors
S Ortiz-Cuaran, M Scheffler, D Plenker, L Dahmen, AH Scheel, ...
Clinical Cancer Research 22 (19), 4837-4847, 2016
The system can't perform the operation now. Try again later.
Articles 1–20